Your account is not claimed yet. You can sign up with ORCID to claim your account.

Sara Teresinha Olalla Saad (Sara T Olalla Saad, Sara T Olalla Saad, Sara T Olalla-Saad, Sara T O Saad, S T Olalla Saad, Sara Teresinha Olalla-Saad)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 19

Top Venues

Journal of cellular and molecular medicine

Leukemia & lymphoma

Expert review of hematology

Hemoglobin

This page only lists publications with an associated author ORCID identifier.

Publications

Fernanda Isabel Della Via, Marisa Claudia Alvarez, Rosanna Tarkany Basting, Sara Teresinha Olalla Saad
The Effects of Green Tea Catechins in Hematological Malignancies. Pharmaceuticals (Basel, Switzerland) 16 (7) (2023)
Aderson da Silva Araújo, Ana Cristina Silva Pinto, Clarisse Lopes de Castro Lobo, Maria Stella Figueiredo, Sandra Fátima Menosi Gualandro, Sara Teresinha Olalla Saad, Rodolfo Delfini Cancado
Novel Insights into the Pathophysiology and Treatment of Sickle Cell Disease. Hemoglobin (2023)
Lidiane S Torres, Hanan Chweih, Fernanda C Z Fabris, Erica M F Gotardo, Flávia C Leonardo, Sara Teresinha Olalla Saad, Fernando F Costa, Nicola Conran
TGF-β1 Reduces Neutrophil Adhesion and Prevents Acute Vaso-Occlusive Processes in Sickle Cell Disease Mice. Cells 11 (7) (2022)
Rogério José Machado Júnior, Júlia C Camilli, Rosanna Tarkany Basting, Patrícia Maria Wiziacki Zago, Ilza Maria de Oliveira Sousa, Kaio Eduardo Buglio, Ana Lúcia Tasca Gois Ruiz, Paulo Roberto Nogueira Carvalho, João Ernesto de Carvalho, Sara Teresinha Olalla Saad, Mary Ann Foglio
Cytoprotective effect of Fridericia chica (Bonpl.) L.G. Lohmann extract associated with geranylgeraniol enriched-fraction from Bixa orellana L. on epithelial cells treated with bisphosphonate. Natural product research (2022)
Rubia Isler Mancuso, Sara Teresinha Olalla Saad, Juliana Hofstätter Azambuja
Artesunate Switches Monocytes to an Inflammatory Phenotype with the Ability to Kill Leukemic Cells. International journal of molecular sciences 22 (2) (2021)
Cristiane Okuda Torello, Marisa Claudia Alvarez, Sara Teresinha Olalla Saad
Polyphenolic Flavonoid Compound Quercetin Effects in the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndromes. Molecules (Basel, Switzerland) 26 (19) (2021)
Ademar Dantas da Cunha Júnior, Dalila Luciola Zanette, Fernando Vieira Pericole, Sara Teresinha Olalla Saad, José Barreto Campello Carvalheira
Obesity as a Possible Risk Factor for Progression from Monoclonal Gammopathy of Undetermined Significance Progression into Multiple Myeloma: Could Myeloma Be Prevented with Metformin Treatment? Advances in hematology 2021 (2021)
Lidiane S Torres, Lediana I M Teles, Merav E Shaul, Zvi G Fridlender, Irene Santos, Flávia C Leonardo, Paula de Melo Campos, Bruno Deltreggia Benites, Sara Teresinha Olalla Saad, Fernando F Costa, Nicola Conran
Accelerated low-density neutrophil transition in sickle cell anaemia may contribute to disease pathophysiology. British journal of haematology 197 (2) (2021)
Fernanda Isabel Della Via, Rodrigo Naoto Shiraishi, Irene Santos, Karla Priscila Ferro, Myriam Janeth Salazar-Terreros, Gilberto Carlos Franchi Junior, Eduardo Magalhães Rego, Sara Teresinha Olalla Saad, Cristiane Okuda Torello
(-)-Epigallocatechin-3-gallate induces apoptosis and differentiation in leukaemia by targeting reactive oxygen species and PIN1. Scientific reports 11 (1) (2021)
Rubia Isler Mancuso, Juliana Hofstätter Azambuja, Fernanda Soares Niemann, Ada Congrains, Mary Ann Foglio, Eduardo Magalhães Rego, Sara Teresinha Olalla Saad
Artemisinins induce endoplasmic reticulum stress in acute leukaemia cells in vitro and in vivo. EJHaem 2 (4) (2021)
Ada Congrains, Juares Bianco, Renata G Rosa, Rubia Isler Mancuso, Sara Teresinha Olalla Saad
3D Scaffolds to Model the Hematopoietic Stem Cell Niche: Applications and Perspectives. Materials (Basel, Switzerland) 14 (3) (2021)
Rubia Isler Mancuso, Mary Ann Foglio, Sara Teresinha Olalla Saad
Artemisinin-type drugs for the treatment of hematological malignancies. Cancer chemotherapy and pharmacology 87 (1) (2020)
Lorena Bedotti Ribeiro, Eliane Alves Soares, Fernando Ferreira Costa, Simone Cristina Olenscki Gilli, Sara Teresinha Olalla Saad, Bruno Deltreggia Benites
The challenges of handling deferasirox in sickle cell disease patients older than 40 years. Hematology (Amsterdam, Netherlands) 24 (1) (2020)
Francisco A Ferreira, Bruno Deltreggia Benites, Fernando F Costa, Simone Gilli, Sara Teresinha Olalla Saad
Recombinant erythropoietin as alternative to red cell transfusion in sickle cell disease. Vox sanguinis 114 (2) (2019)
Bruno Deltreggia Benites, Sara Teresinha Olalla Saad
An update on arginine in sickle cell disease. Expert review of hematology 12 (4) (2019)
Ada Congrains-Castillo, Fernanda S Niemann, Adriana S Santos Duarte, Sara Teresinha Olalla Saad
LEF1-AS1, long non-coding RNA, inhibits proliferation in myeloid malignancy. Journal of cellular and molecular medicine 23 (4) (2019)
Luciana Bueno De Paiva, Vanessa Aline Bernusso, João Agostinho Machado-Neto, Fabiola Traina, Anne J Ridley, Sara Teresinha Olalla Saad, Mariana Lazarini
Effects of RhoA and RhoC upon the sensitivity of prostate cancer cells to glutamine deprivation. Small GTPases 12 (1) (2018)
Fernanda Marconi Roversi, Nathalia Moreno Cury, Matheus Rodrigues Lopes, Karla Priscila Ferro, João Agostinho Machado-Neto, Marisa Claudia Alvarez, Gabriela Pereira Dos Santos, Renata Giardini Rosa, Ana Leda Longhini, Adriana da Silva Santos Duarte, Fernando Vieira Pericole, Patricia Favaro, José Andres Yunes, Sara Teresinha Olalla Saad
Up-regulation of SPINT2/HAI-2 by Azacytidine in bone marrow mesenchymal stromal cells affects leukemic stem cell survival and adhesion. Journal of cellular and molecular medicine 23 (2) (2018)
Flávia Adolfo Corrocher, Luciana Bueno De Paiva, Adriana Silva Santos Duarte, Karla Priscila Ferro, Leonardo Dos Reis Silveira, Tanes Iamamura de Lima, Sara Teresinha Olalla Saad, Mariana Lazarini
Reduced expression of NR4A1 activates glycolytic pathway in acute promyelocytic leukemia cells. Leukemia & lymphoma 59 (6) (2017)

Sara Teresinha Olalla Saad.css-eqlu8i{font-size:small;padding-left:4px;} (Sara T Olalla Saad, Sara T Olalla Saad, Sara T Olalla-Saad, Sara T O Saad, S T Olalla Saad, Sara Teresinha Olalla-Saad)

Publication Activity (10 Years)

Top Topics

Top Venues

Sara Teresinha Olalla Saad (Sara T Olalla Saad, Sara T Olalla Saad, Sara T Olalla-Saad, Sara T O Saad, S T Olalla Saad, Sara Teresinha Olalla-Saad)